RU2266543C2 - Реагентные системы для детектирования восстановленного кофактора - Google Patents

Реагентные системы для детектирования восстановленного кофактора Download PDF

Info

Publication number: RU2266543C2
Authority: RU; Russia
Prior art keywords: signal generation; electron transfer; generation system; sample; enzyme
Prior art date: 2000-03-28

Application number

RU2002123839/15A

Other languages

English (en)

Russian (ru)

Other versions

RU2002123839A (ru

Inventor

Тианмей ОУЯНГ (US)

Тианмей ОУЯНГ

Original Assignee

Лайфскен, Инк.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-28

Filing date

2001-03-08

Publication date

2005-12-20

2001-03-08 Application filed by Лайфскен, Инк. filed Critical Лайфскен, Инк.

2004-03-10 Publication of RU2002123839A publication Critical patent/RU2002123839A/ru

2005-12-20 Application granted granted Critical

2005-12-20 Publication of RU2266543C2 publication Critical patent/RU2266543C2/ru

Links

239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 42
230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 claims abstract description 44
102000004190 Enzymes Human genes 0.000 claims abstract description 35
108090000790 Enzymes Proteins 0.000 claims abstract description 35
239000012992 electron transfer agent Substances 0.000 claims abstract description 32
239000000203 mixture Substances 0.000 claims abstract description 32
238000012360 testing method Methods 0.000 claims abstract description 31
102000004169 proteins and genes Human genes 0.000 claims abstract description 16
108090000623 proteins and genes Proteins 0.000 claims abstract description 16
150000001875 compounds Chemical class 0.000 claims abstract description 15
-1 phenazine compound Chemical class 0.000 claims abstract description 13
230000001590 oxidative effect Effects 0.000 claims abstract description 8
PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims abstract description 7
238000000034 method Methods 0.000 claims description 17
230000033116 oxidation-reduction process Effects 0.000 claims description 13
230000027756 respiratory electron transport chain Effects 0.000 claims description 8
239000003795 chemical substances by application Substances 0.000 claims description 7
239000000523 sample Substances 0.000 abstract description 36
238000006243 chemical reaction Methods 0.000 abstract description 26
239000008280 blood Substances 0.000 abstract description 19
210000004369 blood Anatomy 0.000 abstract description 19
101710088194 Dehydrogenase Proteins 0.000 abstract description 9
238000001514 detection method Methods 0.000 abstract description 8
239000000126 substance Substances 0.000 abstract description 8
239000012472 biological sample Substances 0.000 abstract description 2
239000002824 redox indicator Substances 0.000 abstract description 2
238000004166 bioassay Methods 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
239000012491 analyte Substances 0.000 description 36
RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 17
BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 17
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 14
235000018102 proteins Nutrition 0.000 description 13
238000004458 analytical method Methods 0.000 description 12
229950006238 nadide Drugs 0.000 description 12
239000010410 layer Substances 0.000 description 10
239000000047 product Substances 0.000 description 9
208000008454 Hyperhidrosis Diseases 0.000 description 8
208000013219 diaphoresis Diseases 0.000 description 8
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
125000003831 tetrazolyl group Chemical group 0.000 description 7
WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 6
LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 6
239000000975 dye Substances 0.000 description 6
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
239000000758 substrate Substances 0.000 description 5
VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 4
HAUGRYOERYOXHX-UHFFFAOYSA-N Alloxazine Chemical compound C1=CC=C2N=C(C(=O)NC(=O)N3)C3=NC2=C1 HAUGRYOERYOXHX-UHFFFAOYSA-N 0.000 description 4
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 description 4
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
238000010586 diagram Methods 0.000 description 4
239000008103 glucose Substances 0.000 description 4
ZJTJUVIJVLLGSP-UHFFFAOYSA-N lumichrome Chemical compound N1C(=O)NC(=O)C2=C1N=C1C=C(C)C(C)=CC1=N2 ZJTJUVIJVLLGSP-UHFFFAOYSA-N 0.000 description 4
239000012528 membrane Substances 0.000 description 4
CXONXVMMINSQBV-NNYOXOHSSA-N (2r,3r,4s,5r)-5-[[[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-2-(3-carbamothioylpyridin-1-ium-1-yl)-4-hydroxyoxolan-3-olate Chemical compound NC(=S)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)[O-])=C1 CXONXVMMINSQBV-NNYOXOHSSA-N 0.000 description 3
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
102000001554 Hemoglobins Human genes 0.000 description 3
108010054147 Hemoglobins Proteins 0.000 description 3
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 3
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
229910019142 PO4 Inorganic materials 0.000 description 3
JCDBQDNBEQHDHK-BSLNIGMPSA-N [(2r,3s,4r,5r)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl [[(2r,3s,4r,5r)-3,4-dihydroxy-5-imidazo[2,1-f]purin-3-yloxolan-2-yl]methoxy-hydroxyphosphoryl] phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=C(C5=NC=CN5C=N4)N=C3)O)O2)O)=C1 JCDBQDNBEQHDHK-BSLNIGMPSA-N 0.000 description 3
230000001133 acceleration Effects 0.000 description 3
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
XAZMYOQLNVTRPS-UHFFFAOYSA-L disodium;2-[[4-[2-(1,3-benzothiazol-2-yl)-3-[4-[4-[3-(1,3-benzothiazol-2-yl)-5-[4-[bis(2-sulfonatoethyl)carbamoyl]phenyl]tetrazol-3-ium-2-yl]-3-methoxyphenyl]-2-methoxyphenyl]tetrazol-2-ium-5-yl]benzoyl]-(2-sulfonatoethyl)amino]ethanesulfonate Chemical compound [Na+].[Na+].COC1=CC(C=2C=C(OC)C(=CC=2)N2[N+](=NC(=N2)C=2C=CC(=CC=2)C(=O)N(CCS([O-])(=O)=O)CCS([O-])(=O)=O)C=2SC3=CC=CC=C3N=2)=CC=C1N([N+](=N1)C=2SC3=CC=CC=C3N=2)N=C1C1=CC=C(C(=O)N(CCS([O-])(=O)=O)CCS([O-])(=O)=O)C=C1 XAZMYOQLNVTRPS-UHFFFAOYSA-L 0.000 description 3
239000012530 fluid Substances 0.000 description 3
235000013922 glutamic acid Nutrition 0.000 description 3
239000004220 glutamic acid Substances 0.000 description 3
235000011187 glycerol Nutrition 0.000 description 3
229940116871 l-lactate Drugs 0.000 description 3
239000001630 malic acid Substances 0.000 description 3
235000011090 malic acid Nutrition 0.000 description 3
WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 3
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
239000010452 phosphate Substances 0.000 description 3
229920000728 polyester Polymers 0.000 description 3
229940107700 pyruvic acid Drugs 0.000 description 3
BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 3
239000000243 solution Substances 0.000 description 3
150000003431 steroids Chemical class 0.000 description 3
RONADMZTCCPLEF-UHFFFAOYSA-M tetrazolium violet Chemical compound [Cl-].C1=CC=CC=C1C(N=[N+]1C=2C3=CC=CC=C3C=CC=2)=NN1C1=CC=CC=C1 RONADMZTCCPLEF-UHFFFAOYSA-M 0.000 description 3
238000012546 transfer Methods 0.000 description 3
PVPBBTJXIKFICP-UHFFFAOYSA-N (7-aminophenothiazin-3-ylidene)azanium;chloride Chemical compound [Cl-].C1=CC(=[NH2+])C=C2SC3=CC(N)=CC=C3N=C21 PVPBBTJXIKFICP-UHFFFAOYSA-N 0.000 description 2
YBMDPYAEZDJWNY-UHFFFAOYSA-N 1,2,3,3,4,4,5,5-octafluorocyclopentene Chemical compound FC1=C(F)C(F)(F)C(F)(F)C1(F)F YBMDPYAEZDJWNY-UHFFFAOYSA-N 0.000 description 2
ZYDGCYWJDWIJCS-UHFFFAOYSA-N 1-methoxyphenazine Chemical compound C1=CC=C2N=C3C(OC)=CC=CC3=NC2=C1 ZYDGCYWJDWIJCS-UHFFFAOYSA-N 0.000 description 2
TZMSYXZUNZXBOL-UHFFFAOYSA-N 10H-phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 description 2
JQQLAEIATYLBQN-UHFFFAOYSA-N 2,3-bis(4-nitrophenyl)-1h-tetrazole Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1N(C=2C=CC(=CC=2)[N+]([O-])=O)N=CN1 JQQLAEIATYLBQN-UHFFFAOYSA-N 0.000 description 2
CCBICDLNWJRFPO-UHFFFAOYSA-N 2,6-dichloroindophenol Chemical compound C1=CC(O)=CC=C1N=C1C=C(Cl)C(=O)C(Cl)=C1 CCBICDLNWJRFPO-UHFFFAOYSA-N 0.000 description 2
FTZIQBGFCYJWKA-UHFFFAOYSA-N 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Chemical compound S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 FTZIQBGFCYJWKA-UHFFFAOYSA-N 0.000 description 2
JJMQRJKPLUACSO-UHFFFAOYSA-N 3-(4-iodophenyl)-2-(4-nitrophenyl)-5-phenyl-1,3-dihydrotetrazol-3-ium;chloride Chemical compound [Cl-].C1=CC([N+](=O)[O-])=CC=C1N1N(C=2C=CC(I)=CC=2)[NH2+]C(C=2C=CC=CC=2)=N1 JJMQRJKPLUACSO-UHFFFAOYSA-N 0.000 description 2
VDJKJPMLWJWQIH-UHFFFAOYSA-M 5-ethylphenazin-5-ium;ethyl sulfate Chemical compound CCOS([O-])(=O)=O.C1=CC=C2[N+](CC)=C(C=CC=C3)C3=NC2=C1 VDJKJPMLWJWQIH-UHFFFAOYSA-M 0.000 description 2
AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
101001102158 Homo sapiens Phosphatidylserine synthase 1 Proteins 0.000 description 2
MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical class ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 2
239000004677 Nylon Substances 0.000 description 2
102100039298 Phosphatidylserine synthase 1 Human genes 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
229920002366 Tetronic® 1307 Polymers 0.000 description 2
IURGIPVDZKDLIX-UHFFFAOYSA-M [7-(diethylamino)phenoxazin-3-ylidene]-diethylazanium;chloride Chemical compound [Cl-].C1=CC(=[N+](CC)CC)C=C2OC3=CC(N(CC)CC)=CC=C3N=C21 IURGIPVDZKDLIX-UHFFFAOYSA-M 0.000 description 2
PGWTYMLATMNCCZ-UHFFFAOYSA-M azure A Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 PGWTYMLATMNCCZ-UHFFFAOYSA-M 0.000 description 2
ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
238000001035 drying Methods 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
235000019441 ethanol Nutrition 0.000 description 2
235000001727 glucose Nutrition 0.000 description 2
238000005534 hematocrit Methods 0.000 description 2
150000002576 ketones Chemical class 0.000 description 2
229960003136 leucine Drugs 0.000 description 2
229910001629 magnesium chloride Inorganic materials 0.000 description 2
229940099690 malic acid Drugs 0.000 description 2
YYGBVRCTHASBKD-UHFFFAOYSA-M methylene green Chemical compound [Cl-].C1=CC(N(C)C)=C([N+]([O-])=O)C2=[S+]C3=CC(N(C)C)=CC=C3N=C21 YYGBVRCTHASBKD-UHFFFAOYSA-M 0.000 description 2
VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
229920001778 nylon Polymers 0.000 description 2
238000000253 optical time-domain reflectometry Methods 0.000 description 2
230000003647 oxidation Effects 0.000 description 2
238000007254 oxidation reaction Methods 0.000 description 2
150000002988 phenazines Chemical class 0.000 description 2
MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
239000011541 reaction mixture Substances 0.000 description 2
235000019192 riboflavin Nutrition 0.000 description 2
229960002477 riboflavin Drugs 0.000 description 2
239000002151 riboflavin Substances 0.000 description 2
OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
239000002344 surface layer Substances 0.000 description 2
MUUHXGOJWVMBDY-UHFFFAOYSA-L tetrazolium blue Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 MUUHXGOJWVMBDY-UHFFFAOYSA-L 0.000 description 2
HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
BEIGFKLRGRRJJA-JLHYYAGUSA-O 2-(2f-benzothiazolyl)-5-styryl-3-(4f-phthalhydrazidyl)tetrazolium chloride Chemical compound C=1C=C2C(=O)NNC(=O)C2=CC=1[N+](N(N=1)C=2SC3=CC=CC=C3N=2)=NC=1\C=C\C1=CC=CC=C1 BEIGFKLRGRRJJA-JLHYYAGUSA-O 0.000 description 1
CDJXJFDPAXBVDM-UHFFFAOYSA-N 3,5-diphenyl-2-[4-(2-phenylethenyl)phenyl]-1h-tetrazole Chemical compound N1N(C=2C=CC(C=CC=3C=CC=CC=3)=CC=2)N(C=2C=CC=CC=2)N=C1C1=CC=CC=C1 CDJXJFDPAXBVDM-UHFFFAOYSA-N 0.000 description 1
102000034279 3-hydroxybutyrate dehydrogenases Human genes 0.000 description 1
108090000124 3-hydroxybutyrate dehydrogenases Proteins 0.000 description 1
VALWHFRGYCBHIY-UHFFFAOYSA-N 4-(5-methyl-3-phenyl-1h-tetrazol-2-yl)benzoic acid Chemical compound N1C(C)=NN(C=2C=CC=CC=2)N1C1=CC=C(C(O)=O)C=C1 VALWHFRGYCBHIY-UHFFFAOYSA-N 0.000 description 1
102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
102100039702 Alcohol dehydrogenase class-3 Human genes 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
241000193403 Clostridium Species 0.000 description 1
NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
102100034289 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Human genes 0.000 description 1
102000028526 Dihydrolipoamide Dehydrogenase Human genes 0.000 description 1
108010028127 Dihydrolipoamide Dehydrogenase Proteins 0.000 description 1
QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
108010046335 Ferredoxin-NADP Reductase Proteins 0.000 description 1
VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
102000016901 Glutamate dehydrogenase Human genes 0.000 description 1
101000641031 Homo sapiens Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Proteins 0.000 description 1
102000011145 Hydroxysteroid Dehydrogenases Human genes 0.000 description 1
108010062875 Hydroxysteroid Dehydrogenases Proteins 0.000 description 1
102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
108010028658 Leucine Dehydrogenase Proteins 0.000 description 1
102000013460 Malate Dehydrogenase Human genes 0.000 description 1
108010026217 Malate Dehydrogenase Proteins 0.000 description 1
102000002247 NADPH Dehydrogenase Human genes 0.000 description 1
108010014870 NADPH Dehydrogenase Proteins 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
241000607598 Vibrio Species 0.000 description 1
239000011358 absorbing material Substances 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
239000000370 acceptor Substances 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
238000003556 assay Methods 0.000 description 1
235000013405 beer Nutrition 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
239000004305 biphenyl Substances 0.000 description 1
235000010290 biphenyl Nutrition 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000012937 correction Methods 0.000 description 1
125000000853 cresyl group Chemical group C1(=CC=C(C=C1)C)* 0.000 description 1
238000011161 development Methods 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
150000002211 flavins Chemical class 0.000 description 1
239000011521 glass Substances 0.000 description 1
108010051015 glutathione-independent formaldehyde dehydrogenase Proteins 0.000 description 1
150000004678 hydrides Chemical class 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000000463 material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
229960000907 methylthioninium chloride Drugs 0.000 description 1
FSVCQIDHPKZJSO-UHFFFAOYSA-L nitro blue tetrazolium dichloride Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 FSVCQIDHPKZJSO-UHFFFAOYSA-L 0.000 description 1
150000004893 oxazines Chemical class 0.000 description 1
239000007800 oxidant agent Substances 0.000 description 1
125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
125000001484 phenothiazinyl group Chemical class C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
150000002991 phenoxazines Chemical class 0.000 description 1
125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
229920000172 poly(styrenesulfonic acid) Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920005597 polymer membrane Polymers 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
229940005642 polystyrene sulfonic acid Drugs 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
230000036632 reaction speed Effects 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
239000012488 sample solution Substances 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
230000003595 spectral effect Effects 0.000 description 1
239000012086 standard solution Substances 0.000 description 1
210000001138 tear Anatomy 0.000 description 1
150000003536 tetrazoles Chemical class 0.000 description 1
150000004897 thiazines Chemical class 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
235000012711 vitamin K3 Nutrition 0.000 description 1
239000011652 vitamin K3 Substances 0.000 description 1
229940041603 vitamin k 3 Drugs 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/90212—Oxidoreductases (1.) acting on a sulfur group of donors (1.8)

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Physics & Mathematics (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

RU2002123839/15A 2000-03-28 2001-03-08 Реагентные системы для детектирования восстановленного кофактора RU2266543C2 (ru)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US53720300A	2000-03-28	2000-03-28
US09/537,203		2000-03-28

Publications (2)

Publication Number	Publication Date
RU2002123839A RU2002123839A (ru)	2004-03-10
RU2266543C2 true RU2266543C2 (ru)	2005-12-20

Family

ID=24141653

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
RU2002123839/15A RU2266543C2 (ru)	2000-03-28	2001-03-08	Реагентные системы для детектирования восстановленного кофактора

Country Status (13)

Country	Link
EP (1)	EP1268849A2 (fr)
JP (1)	JP2003528623A (fr)
KR (1)	KR20020089412A (fr)
CN (1)	CN1419604A (fr)
AR (1)	AR027726A1 (fr)
AU (1)	AU2001243542A1 (fr)
CA (1)	CA2404421A1 (fr)
HK (1)	HK1050030A1 (fr)
IL (1)	IL151262A0 (fr)
MX (1)	MXPA02009469A (fr)
PL (1)	PL357180A1 (fr)
RU (1)	RU2266543C2 (fr)
WO (1)	WO2001073114A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050103624A1 (en)	1999-10-04	2005-05-19	Bhullar Raghbir S.	Biosensor and method of making
GB0204232D0 (en) *	2002-02-22	2002-04-10	Isis Innovation	Assay
US7597793B2 (en)	2003-06-20	2009-10-06	Roche Operations Ltd.	System and method for analyte measurement employing maximum dosing time delay
US8148164B2 (en)	2003-06-20	2012-04-03	Roche Diagnostics Operations, Inc.	System and method for determining the concentration of an analyte in a sample fluid
US7604721B2 (en)	2003-06-20	2009-10-20	Roche Diagnostics Operations, Inc.	System and method for coding information on a biosensor test strip
PL1639354T3 (pl)	2003-06-20	2018-11-30	F.Hoffmann-La Roche Ag	Pasek testowy z otworem szczeliny wentylacyjnej
US8071030B2 (en)	2003-06-20	2011-12-06	Roche Diagnostics Operations, Inc.	Test strip with flared sample receiving chamber
US7452457B2 (en)	2003-06-20	2008-11-18	Roche Diagnostics Operations, Inc.	System and method for analyte measurement using dose sufficiency electrodes
US7556723B2 (en)	2004-06-18	2009-07-07	Roche Diagnostics Operations, Inc.	Electrode design for biosensor
US7569126B2 (en)	2004-06-18	2009-08-04	Roche Diagnostics Operations, Inc.	System and method for quality assurance of a biosensor test strip
ITMI20050881A1 (it) *	2005-05-16	2006-11-17	Anna Favre	Kit diagnostico per la malattia di hirschsprung megalon congenito
DE102006002165A1 (de) *	2006-01-17	2007-07-19	Merck Patent Gmbh	Verfahren und Mittel zur enzymatischen Bestimmung von Acetat
WO2011107238A1 (fr) *	2010-03-01	2011-09-09	System Biologie Ag	Bandelette réactive pour la détection d'équol
CN102520198A (zh) *	2011-11-21	2012-06-27	宁波美康生物科技股份有限公司	乙醇浓度检测试剂盒及其制备方法
CN102520150A (zh) *	2011-12-08	2012-06-27	上海高丰医疗电器有限公司	一种伽马-羟基丁酸的测定诊断试纸及其制备方法
US8921061B2 (en)	2012-11-02	2014-12-30	Roche Diagnostics Operations, Inc.	Reagent materials and associated test elements
US8920628B2 (en)	2012-11-02	2014-12-30	Roche Diagnostics Operations, Inc.	Systems and methods for multiple analyte analysis
CN108359710B (zh) *	2018-02-11	2019-04-30	山东大学齐鲁医院	葡萄糖磷酸异构酶的酶显色定量测定试剂盒及测定方法
CN110117791B (zh) *	2019-05-23	2023-11-10	电子科技大学	一种用于高密度互联印制电路板棕化液的结合力促进剂

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4629697A (en) *	1982-12-24	1986-12-16	Merck Patent Gesellschaft Mit Beschrankter Haftung	Test system and procedure for the determination of NAD (P) H
US4824779A (en) *	1984-02-29	1989-04-25	Kyowa Medex Co., Ltd.	Method for the determination of the reduced form of nicotinamide adenine dinucleotide
US5278047A (en) *	1989-04-25	1994-01-11	Lilja Jan E	Method of analysis, reagent composition and use thereof for glucose determination
RU2114914C1 (ru) *	1993-04-08	1998-07-10	Берингер Маннхайм ГмбХ	Способ, средство, тест-система для колориметрического определения аналита и нитрозоанилиновые соединения
US5902731A (en) *	1998-09-28	1999-05-11	Lifescan, Inc.	Diagnostics based on tetrazolium compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5036000A (en) *	1986-12-16	1991-07-30	Enzymatics, Inc.	Threshold color control system

2001
- 2001-03-08 KR KR1020027012698A patent/KR20020089412A/ko not_active Ceased
- 2001-03-08 CN CN01806937A patent/CN1419604A/zh active Pending
- 2001-03-08 PL PL01357180A patent/PL357180A1/xx not_active Application Discontinuation
- 2001-03-08 HK HK03102161.6A patent/HK1050030A1/zh unknown
- 2001-03-08 MX MXPA02009469A patent/MXPA02009469A/es unknown
- 2001-03-08 IL IL15126201A patent/IL151262A0/xx unknown
- 2001-03-08 RU RU2002123839/15A patent/RU2266543C2/ru not_active IP Right Cessation
- 2001-03-08 EP EP01916527A patent/EP1268849A2/fr not_active Withdrawn
- 2001-03-08 WO PCT/US2001/007619 patent/WO2001073114A2/fr not_active Ceased
- 2001-03-08 AU AU2001243542A patent/AU2001243542A1/en not_active Abandoned
- 2001-03-08 JP JP2001570828A patent/JP2003528623A/ja active Pending
- 2001-03-08 CA CA002404421A patent/CA2404421A1/fr not_active Abandoned
- 2001-03-27 AR ARP010101443A patent/AR027726A1/es unknown

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4629697A (en) *	1982-12-24	1986-12-16	Merck Patent Gesellschaft Mit Beschrankter Haftung	Test system and procedure for the determination of NAD (P) H
US4824779A (en) *	1984-02-29	1989-04-25	Kyowa Medex Co., Ltd.	Method for the determination of the reduced form of nicotinamide adenine dinucleotide
US5278047A (en) *	1989-04-25	1994-01-11	Lilja Jan E	Method of analysis, reagent composition and use thereof for glucose determination
RU2114914C1 (ru) *	1993-04-08	1998-07-10	Берингер Маннхайм ГмбХ	Способ, средство, тест-система для колориметрического определения аналита и нитрозоанилиновые соединения
US5902731A (en) *	1998-09-28	1999-05-11	Lifescan, Inc.	Diagnostics based on tetrazolium compounds

Also Published As

Publication number	Publication date
JP2003528623A (ja)	2003-09-30
HK1050030A1 (zh)	2003-06-06
PL357180A1 (en)	2004-07-26
CA2404421A1 (fr)	2001-10-04
AR027726A1 (es)	2003-04-09
RU2002123839A (ru)	2004-03-10
CN1419604A (zh)	2003-05-21
IL151262A0 (en)	2003-04-10
AU2001243542A1 (en)	2001-10-08
WO2001073114A3 (fr)	2002-03-28
WO2001073114A2 (fr)	2001-10-04
EP1268849A2 (fr)	2003-01-02
MXPA02009469A (es)	2003-02-24
KR20020089412A (ko)	2002-11-29

Publication	Publication Date	Title
RU2266543C2 (ru)	2005-12-20	Реагентные системы для детектирования восстановленного кофактора
EP1317563B1 (fr)	2005-11-23	Bandes d'essai avec membranes chargees positivement pour des essais avec tetrazolium
US6586199B2 (en)	2003-07-01	Stabilized tetrazolium reagent compositions and methods for using the same
AU763065B2 (en)	2003-07-10	Diagnostics based on tetrazolium compounds
US4361648A (en)	1982-11-30	Color fixed chromogenic analytical element
EP0463524B1 (fr)	1996-03-06	Composé et procédé pour l'essai des corps kétoniques
US6939685B2 (en)	2005-09-06	Stabilized tetrazolium phenazine reagent compositions and methods for using the same
US5510245A (en)	1996-04-23	Composition and method of assaying for ketone bodies
HK1053856B (en)	2006-05-04	Test-strips with positively charged membranes for tetrazolium based assays
AU2001288935A2 (en)	2003-03-27	Test-strips with positively charged membranes for tetrazolium based assays
HK1025604A (en)	2000-11-17	Diagnostics based on tetrazolium compounds
HK1025604B (en)	2003-01-30	Diagnostics based on tetrazolium compounds
HK1026001B (en)	2003-01-17	Diagnostics based on tetrazolium compounds

Legal Events

Date	Code	Title	Description
2020-12-08	MM4A	The patent is invalid due to non-payment of fees	Effective date: 20200309